Arrhythmias and conductance disturbances and heart failure

Czech version

Authors: Jiří Vítovec ¹; Jindřich Špinar ²; Lenka Špinarová ¹
Authors‘ workplace: I. interní kardio-angiologická klinika LF MU a FN u sv. Anny v Brně ¹; Interní kardiologická klinika LF MU a FN Brno, pracoviště Bohunice ²
Published in: Vnitř Lék 2018; 64(9): 874-877
Category: Reviews

Overview

Arrhythmias and conductance disturbances and heart failure have a close relation. Arrhythmias are serious complication, but also etiology of heart failure. So it is not clear, what is the cause and what is a consequence. Atrial fibrillation is a frequent cause, ventricular arrhythmias a frequent consequence and ventricular fibrillation a frequent cause of death in patients with heart failure. Overview are about frequent arrhythmias as well as their therapy with regard to left ventricular dysfunction.

Key words:

arrhythmias – heart failure

Sources

Ponikowski P, Voors AA, Anker SD et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2016; 37(27): 2129–2200. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehw128>.
Špinar J, Hradec J, Špinarová L et al. Summary of the 2016 ESC Guidelines on the diagnosis and treatment of acute and chronic heart failure. Prepared by the Czech Society of Cardiology. Cor Vasa 2016; 58(5): e530-e568. Dostupné z DOI: <https://doi.org/10.1016/j.crvasa.2016.09.004>.
Vítovec J, Špinar J, Špinarová L et al. Léčba kardiovakulárníchh onemocnění. Praha: Grada Publishing 2018. ISBN 978–80–271–0624–0.
Smit MD, Moes ML, Maass AH et al. The importance of whether atrial fibrillation or heart failure develops first. Eur J Heart Fail 2012; 14(9): 1030–1040. Dostupné z DOI: <http://dx.doi.org/10.1093/eurjhf/hfs097>.
Hess PL, Jackson KP, Hasselblad V et al. Is cardiac resynchronization therapy an antiarrhythmic therapy for atrial fibrillation? A systematic review and meta-analysis. Curr Cardiol Rep 2013; 15(2): 330. Dostupné z DOI: <http://dx.doi.org/10.1007/s11886–012–0330–6>.
Connolly SJ, Camm AJ, Halperin JL et al. Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med 2011; 365(24): 2268–2276. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1109867>.
Hofmann R, Steinwender C, Kammler J et al. Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate. Int J Cardiol 2006; 110(1): 27–32. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ijcard.2005.06.048>.
Kirchhof P, Benussi S, Kotecha D et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016; 37(38): 2893–2962. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehw210>.
Roy D, Talajic M, Nattel S et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008; 358(25): 2667–2677. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa0708789>.
Marrouche NF, Brachmann J, Andresen D et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 2018; 378(5): 417–427. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1707855>.
Čihák R, Haman L, Táborský M. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Summary of the document prepared by the Czech Society of Cardiology. Cor Vasa 2016; 58(6): e636-e683. Dostupné z DOI: <http://dx.doi.org/10.1016/j.crvasa.2016.11.005>.
Kautzner J, Osmančík P. Summary of the 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Prepared by the Czech Society of Cardiology. Cor Vasa 2016; 58(1): e29-e80. Dostupné z DOI: <http://dx.doi.org/10.1016/j.crvasa.2016.01.009>.
Táborský M, Kautzner J. Summary of the 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Prepared by the Czech Society of Cardiology. Cor Vasa 2014; 5(1): e57-e74. Dostupné z DOI: <https://doi.org/10.1016/j.crvasa.2013.12.001>.

Labels

Diabetology Endocrinology Internal medicine

Pathophysiology, causes and epidemiology of chronic heart failure

What we know about epidemiology of heart failure in Slovakia and globally

Diagnosis of heart failure: the new classification of heart failure

Pharmacological therapy for chronic heart failure

Comorbidities in heart failure

The heart transplantation

Otto Kahler and his family (on the 125th anniversary of his death): I. Ancestors

Outpatient treatment of proximal deep vein thrombosis

Article was published in

Internal Medicine

2018 Issue 9